John S. Yu - Concepedia

Author

John S. Yu

Cedars-Sinai Medical Center ORCID

Also Known As

B. S, Bentham Science Publisher Yu John S, Bindu I.S., Brigida K.S., J S Yu, J Yu, J. S. YU, J. S. Yu, J. YU, J. Yu

322

Publications

11.8K

Citations

H-Index

215

Concepts

All Affiliations

Cedars-Sinai Medical Center Massachusetts General Hospital NeuroSpine Institute University of California, Los Angeles Children's Hospital at Westmead

About

John S. Yu is an author at Cedars-Sinai Medical Center specializing in medicine, glioma, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	57	4.9K
2	Engineering	9	9	623
3	Health Sciences	6	6	1.3K
4	Education	1	1	29
5	Natural Sciences	1	1	29

John S. Yu

100

Publications

10.8K

Citations

H-Index

Page 1

	Year	Citations
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Gentao Liu, Xiangpeng Yuan, Zhaohui Zeng, Molecular Cancer	2006	1.8K
Isolation of cancer stem cells from adult glioblastoma multiforme Xiangpeng Yuan, James F. Curtin, Yizhi Xiong, Oncogene Neuro-oncologyGliomaMedicineAdult Stem CellStem Cell Research	2004	789
Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma John S. Yu, Gentao Liu, Ying Han, Cancer Research	2004	530
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. John S. Yu, Christopher J. Wheeler, Paul M. Zeltzer, PubMed ImmunologyPathologyImmunotherapyGliomaNeuro-oncology	2001	514
Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma Surasak Phuphanich, Christopher J. Wheeler, Jeremy Rudnick, Cancer Immunology Immunotherapy	2012	378
The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Moneeb Ehtesham, Peter Kabos, Andrea Kabosova, PubMed Cell TherapyT-regulatory CellImmunologyHigh-grade GliomasImmunotherapy	2002	311
Vaccination Elicits Correlated Immune and Clinical Responses in Glioblastoma Multiforme Patients Christopher J. Wheeler, Keith L. Black, Gentao Liu, Cancer Research	2008	291
Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination Christopher J. Wheeler, Asha Das, Gentao Liu, Clinical Cancer Research	2004	267
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma Patrick Y. Wen, David A. Reardon, Terri S. Armstrong, Clinical Cancer Research	2019	259
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, Science Translational Medicine ImmunologyImmunoeditingRecurrent High-grade GliomaImmunotherapeuticsHigh-grade Gliomas	2019	252

Page 1